Page last updated: 2024-10-16

carbamates and Erythremia

carbamates has been researched along with Erythremia in 6 studies

Research Excerpts

ExcerptRelevanceReference
" In this multicentre, open-label, phase II study, 44 patients with polycythaemia vera (PV), unresponsive to the maximum tolerated doses (MTD) of hydroxycarbamide (HC), were treated with Givinostat (50 or 100 mg/d) in combination with MTD of HC."2.78A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. ( Barbui, T; Barosi, G; Cilloni, D; Demuth, T; Finazzi, G; Finazzi, MC; Fioritoni, G; Martinelli, V; Musolino, C; Nobile, F; Olimpieri, OM; Pogliani, EM; Rambaldi, A; Ruggeri, M; Sivera, P; Specchia, G; Tollo, SD; Vannucchi, AM, 2013)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Rambaldi, A4
Iurlo, A2
Vannucchi, AM3
Noble, R1
von Bubnoff, N2
Guarini, A2
Martino, B2
Pezzutto, A1
Carli, G1
De Muro, M2
Luciani, S2
McMullin, MF2
Cambier, N1
Marolleau, JP1
Mesa, RA1
Tibes, R1
Pancrazzi, A1
Gesullo, F1
Bettica, P2
Manzoni, S2
Di Tollo, S2
Chifotides, HT1
Bose, P1
Verstovsek, S1
Ruggeri, M2
Martinelli, V2
Nogai, A1
Rosti, V1
Ricco, A1
Finazzi, G2
Nobile, F1
Specchia, G1
Pogliani, EM1
Olimpieri, OM1
Fioritoni, G1
Musolino, C1
Cilloni, D1
Sivera, P1
Barosi, G1
Finazzi, MC1
Tollo, SD1
Demuth, T1
Barbui, T1
Yoshimoto, G1
Miyamoto, T1
Amaru Calzada, A1
Pedrini, O1
Leoni, F1
Mascagni, P1
Introna, M1
Golay, J1

Reviews

2 reviews available for carbamates and Erythremia

ArticleYear
Givinostat: an emerging treatment for polycythemia vera.
    Expert opinion on investigational drugs, 2020, Volume: 29, Issue:6

    Topics: Animals; Carbamates; Disease Progression; Histone Deacetylase Inhibitors; Humans; Hydroxyurea; Janus

2020
[Treatment strategy for myeloproliferative neoplasms].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

    Topics: Adrenal Cortex Hormones; Aspirin; Calreticulin; Carbamates; Clinical Trials as Topic; Drug Therapy,

2014

Trials

3 trials available for carbamates and Erythremia

ArticleYear
Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study.
    Leukemia, 2020, Volume: 34, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Carbamates; Female; Humans; Janus Kinase 2; Male; Maximum Tolerated

2020
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program.
    Blood cancer journal, 2021, 03-06, Volume: 11, Issue:3

    Topics: Adult; Aged; Carbamates; Female; Follow-Up Studies; Histone Deacetylase Inhibitors; Humans; Male; Mi

2021
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.
    British journal of haematology, 2013, Volume: 161, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Carbamates; Dose-Response Relationship, Drug; Drug Administration Sc

2013

Other Studies

1 other study available for carbamates and Erythremia

ArticleYear
Givinostat and hydroxyurea synergize in vitro to induce apoptosis of cells from JAK2(V617F) myeloproliferative neoplasm patients.
    Experimental hematology, 2013, Volume: 41, Issue:3

    Topics: Amino Acid Substitution; Antineoplastic Agents; Apoptosis; Blotting, Western; Carbamates; Caspase 3;

2013